Weekender 5/15/15

To Our New Jersey Life Sciences Community:

Welcome to another edition of The Weekender.

It’s Been a Banner Week for the New Jersey Life Sciences Community
At the State level, Biosimilars legislation (A2477) was approved by the Assembly in a unanimous vote (72-0). This legislation allows pharmacists to substitute biosimilar products as long as the conditions set forth in the bill are met.¬†At the Federal level, an updated draft of the 21st Century Cures Act was advanced through the House Energy and Commerce Committee, Subcommittee on Health, marking an important step in delivering #Cures2015 to the President’s desk this year.

BioNJ Members Make FierceBiotech’s “25 Most Influential People in Biopharma” List
Congratulations to BioNJ Members Brent Saunders, Actavis; Bob Hugin, Celgene; David Epstein, Novartis; Serge Weinberg, Sanofi; and Flemming Ornskov, Shire for being placed on FierceBiotech’s list of the “25 Most Influential People in Biopharma.” This is a great accomplishment that makes New Jersey look good and BioNJ proud!

Click here
for this week’s Weekender.